CloudCath, a medtech company based in San Francisco, has created the CloudCath system, a remote monitoring technology that provides clinicians with data on the spent dialysate fluid of at-home peritoneal dialysis patients. CloudCath is incorporated into the drain line of peritoneal dialysis systems, and wirelessly transmits data to the cloud, with (Read more...)
Tag: Exclusive
Aortic Occlusion to Enhance Blood Flow to Brain and Heart: Interview with Habib Frost, CEO of Neurescue
Neurescue, a medtech company based in Denmark, created the NEURESCUE system, a balloon catheter designed to occlude the aorta, resulting in a significant increase in blood flow to the heart and brain. The mechanism is intended to provide emergency treatment for patients suffering a hemorrhage or cardiac arrest. Both hemorrhage and cardiac arrest re (Read more...)
Rapid Diagnosis of Infectious Disease at Point of Care: Interview with Shawn Marcel, CEO of Torus Biosystems
Torus Biosystems, a medtech startup that spun out of Harvard’s Wyss Institute for Biologically Inspired Engineering, has developed the Synestia system, a point of care diagnostic tool for infectious disease. The system aims to provide rapid, point-of-care identification of pathogens, and incorporates microarray and qPCR technology. &nbs (Read more...)
Mobility-Enabled Compression Device for Lymphedema: Interview with CEO of Koya Medical
Koya Medical, a medtech company based in California, has developed the Dayspring active compression system for the treatment of lymphedema. The company received FDA clearance for the use of Dayspring on the upper extremities in June 2020, and just recently announced 510(k) clearance for use in the lower extremities. Lymphedema involves impaired lym (Read more...)
Anti-Restenotic Drug Delivery with the AGENT Drug-Coated Balloon: Interview with Dr. Ian Meredith, Global CMO, Boston Scientific
Boston Scientific recently announced a clinical trial of its AGENT drug coated balloon. The device is coated with paclitaxel, an anti-restenotic drug, and aims to deliver the medication to the affected vessel wall during a percutaneous procedure. Coronary in-stent restenosis (ISR) is caused by occlusive scar tissue that develops in the stented port (Read more...)
Localized Prostate Cancer Therapy: Interview with Shyam Natarajan, CEO of Avenda Health
Avenda Health, a medtech company based in Santa Monica, California has developed the Focal Therapy System. It provides AI-powered prostate cancer therapy with the aim of treating only tumorous tissues, while reducing side-effects compared with conventional therapies. The system recently received FDA breakthrough designation. At present, ther (Read more...)
Diagnosing Acute Compartment Syndrome: Interview with Charles Allan, CEO of MY01
MY01, a medtech company based in Montreal, has developed the Continuous Compartment Pressure Monitor, a sterile, single-use device for the diagnosis of acute compartment syndrome. If undiagnosed and untreated, acute compartment syndrome, a condition caused by high pressure around muscles typically following an injury, can have significant consequen (Read more...)
AirPop Active+ Halo Smart Mask: Medgadget Review
It’s often said that “necessity is the mother of invention,” and that has certainly shown to be true with the ongoing COVID-19 pandemic. One medical product that has seen a re-innovation of sorts, in both fashion and function, is the face covering. What has been historically an item seen primarily in healthcare and industrial sett (Read more...)
When HIPAA is Outpaced by Technology and the Cyber-Elephant We Need Confront: Exclusive with CEO of VigiTrust
Mathieu Gorge is the author of The Cyber-Elephant in the Boardroom, as well as CEO and founder of VigiTrust, which provides Integrated Risk Management SaaS solutions to clients in 120 countries across various industries. He helps CEOs, CxOs, and boards of directors handle cyber accountability challenges through good cyber hygiene and proactive cybe (Read more...)
PerQseal+ for Large Diameter Arterial Closure: Interview with Andrew Glass, CEO of Vivasure Medical
Vivasure Medical, a medtech company based in Galway, Ireland, has developed the PerQseal device, a synthetic implant designed to seal large bore blood vessel punctures. The implant has utility in a wide variety of transcatheter endovascular procedures, such as transcatheter aortic valve replacement (TAVR), thoracic endovascular aneurysm repair (TEV (Read more...)
GARNET Pathogen Filter to Treat Sepsis: Exclusive with Nisha Varma, COO of BOA Biomedical
Sepsis is caused by an uncontrolled spread of infectious pathogens and release of toxins that can lead to systemic inflammation, multi-organ failure, and even death. The pathogens responsible for causing sepsis are usually difficult to identify, and patients are routinely treated with broad spectrum antibiotics. However, dead pathogens remaining in (Read more...)
GI Genius Polyp Detection System: Interview with Giovanni Di Napoli, President, Gastrointestinal at Medtronic
We recently reported on the de novo FDA clearance received by Medtronic for its GI Genius AI polyp detection system. The product is hugely flexible as it works with any video colonoscope and provides AI powered assistance for clinicians in identifying colorectal polyps during colonoscopies. Medtronic reports that the system has significantly improv (Read more...)
Healthcare AI, Limiting Biases, and Gold Standard Data Sets: Exclusive with Vatsal Ghiya, CEO of Shaip
Shaip is an online platform that focuses on healthcare AI data solutions and offers licensed healthcare data designed to help construct AI models. It provides text-based patient medical records and claims data, audio such as physician recordings or patient/doctor conversations, and images and video in the form of X-rays, CT scans, and MRI resu (Read more...)
Non-Surgical Solution for Fecal Incontinence: Interview with Miles Rosen, CEO of Pelvalon
Fecal incontinence can be extremely challenging for those who suffer it. The condition can be embarrassing, making it difficult for people to tell others or even their doctor about it, and it is more common than you might think. Fecal incontinence can affect anyone, but a key group of patients includes women during menopause, in […]
Hope, Resilience & Healing in the COVID-19 Era: A Virtual Conference Report
Well-being and health cannot solely rely upon symptomatic treatment. In fact, “good health” cannot be truly achieved unless the root causes of dis-eases are addressed. Even more ideal is the approach of preventative and integrative medicine, in which lifestyle and behavior changes are made holistically, in conjunction with any necessary (Read more...)
Hummingbird Device for Ear Tube Placement: Interview with Steve Anderson, CEO of Preceptis Medical
In the United States approximately 1 million children undergo ear tube placement every year. The tubes are typically needed when there’s excess fluid in the middle ear and to address chronic ear infections. The tubes help to prevent this fluid build-up but require placement under general anesthesia. General anesthesia can be distressing for c (Read more...)
Polymer Technologies for Tissue Repair: Interview with Christophe Bancel, TISSIUM CEO
TISSIUM, a Paris-based medtech firm, has been named a French Tech 120 company for the 2021 program. TISSIUM, previously called Gecko Biomedical, is developing a suite of polymer technologies and associated delivery devices for tissue repair applications. French Tech 120 is a French government driven program designed to support a total of 120 late-s (Read more...)
Medical Robotics and The Future of Surgery: Interview with Tracy Accardi, VP of R&D at Medtronic
Medtronic has been a key player in the minimally invasive surgery space for the last few decades, and has made great strides more recently in robotic surgery with last year’s acquisition of Digital Surgery. As a quick reference point: despite the many benefits of robotic-assisted surgery (RAS), only 3% of surgeries around the world are [&hell (Read more...)
Improving Structural Heart Disease Care: Interview with Joel Portice, egnite CEO
egnite, a digital healthcare company based in California, offers the CardioCare, an AI-based solution that aims to help clinicians identify and treat patients with structural heart disease. CardioCare is already used in over 50 hospitals in the US. The company reports that structural heart disease can sometimes be undertreated or not identified in (Read more...)
Intraoral Stimulation for Obstructive Sleep Apnea: Interview with Akhil Tripathi, CEO of Signifier Medical
Signifier Medical Technologies, a company with headquarters in London, UK and Massachusetts, has created a new treatment for obstructive sleep apnea, and it is the first to be used during waking hours. Unlike conventional sleep apnea devices, the eXciteOSA is designed to be used for short periods during the day and employs electrical stimulation to (Read more...)